Smith+Nephew Makes Commercial Changes to Address Evolving Market

Smith+Nephew reported 3Q21 orthopedic sales of $868.5 million, +2.7% vs. 3Q20 and -0.1% vs. 3Q19. Despite the Delta variant's impact on orthopedic surgery volumes and the company's ongoing supply chain challenges, Smith+Nephew still expects to achieve the low end of its 2021 guidance of underlying growth in the range of +10% to +13% over...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us